The CRL3BTBD9 E3 ubiquitin ligase complex targets TNFAIP1 for degradation to suppress cancer cell migration
Open Access
- 24 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Signal Transduction and Targeted Therapy
- Vol. 5 (1), 1-9
- https://doi.org/10.1038/s41392-020-0140-z
Abstract
Tumor necrosis factor alpha-induced protein 1 (TNFAIP1) modulates a plethora of important biological processes, including tumorigenesis and cancer cell migration. However, the regulatory mechanism of TNFAIP1 degradation remains largely elusive. In the present study, with a label-free quantitative proteomic approach, TNFAIP1 was identified as a novel ubiquitin target of the Cullin-RING E3 ubiquitin ligase (CRL) complex. More importantly, Cul3-ROC1 (CRL3), a subfamily of CRLs, was identified to specifically interact with TNFAIP1 and promote its polyubiquitination and degradation. Mechanistically, BTBD9, a specific adaptor component of CRL3 complex, was further defined to bind and promote the ubiquitination and degradation of TNFAIP1 in cells. As such, downregulation of BTBD9 promoted lung cancer cell migration by upregulating the expression of TNFAIP1, whereas TNFAIP1 deletion abrogated this effect. Finally, bioinformatics and clinical sample analyses revealed that BTBD9 was downregulated while TNFAIP1 was overexpressed in human lung cancer, which was associated with poor overall survival of patients. Taken together, these findings reveal a previously unrecognized mechanism by which the CRL3(BTBD9) ubiquitin ligase controls TNFAIP1 degradation to regulate cancer cell migration.Funding Information
- National Natural Science Foundation of China (81820108022, 81772470, 81602072, 81772459)
This publication has 47 references indexed in Scilit:
- Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancerEBioMedicine, 2019
- Functional analysis of Cullin 3 E3 ligases in tumorigenesisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2018
- Cullin 3 as a novel target in diverse pathologiesRedox Biology, 2013
- Role of tumor necrosis factor alpha-induced protein 1 in paclitaxel resistanceOncogene, 2013
- NEDD8 Pathways in Cancer, Sine Quibus NonCancer Cell, 2011
- Substrate-Assisted Inhibition of Ubiquitin-like Protein-Activating Enzymes: The NEDD8 E1 Inhibitor MLN4924 Forms a NEDD8-AMP Mimetic In SituMolecular Cell, 2010
- CK2 phosphorylates TNFAIP1 to affect its subcellular localization and interaction with PCNAMolecular Biology Reports, 2009
- Targeting NEDD8-Activated Cullin-RING Ligases for the Treatment of CancerClinical Cancer Research, 2009
- Novel substrates and functions for the ubiquitin-like molecule NEDD8Biochemical Society Transactions, 2008
- Function and regulation of cullin–RING ubiquitin ligasesNature Reviews Molecular Cell Biology, 2005